Vernalis

Challenge: Vernalis, a world leader in fragment and structure-based drug discovery with over twenty-five years of experience, needed a professional website that could clearly communicate their extensive scientific capabilities to pharmaceutical partners. The site needed to showcase disciplines spanning protein production, biophysics, medicinal chemistry, cell biology, and DMPK, while reflecting the credibility and expertise of a company working with major pharmaceutical organisations.

Solution: We developed a website that presents Vernalis's comprehensive service offering in a clear and structured way. The site highlights their proprietary PAC-FragmentDEL platform, collaborative approach, and notable partnerships with organisations including Servier, Pierre Fabre, Genentech, and Lundbeck. The design is professional and science-focused, with intuitive navigation that makes it easy for potential partners to explore their capabilities.

Results: The website provides Vernalis with a strong digital presence that reflects their position as a leading drug discovery partner. Based at Granta Park, Cambridge, and part of the HitGen group of companies, the site helps connect them with pharmaceutical organisations seeking expert collaboration on short-term projects and long-term multi-target programmes.